Correlation Between Alcoa Corp and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alcoa Corp and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alcoa Corp and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alcoa Corp and Neoleukin Therapeutics, you can compare the effects of market volatilities on Alcoa Corp and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alcoa Corp with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alcoa Corp and Neoleukin Therapeutics.
Diversification Opportunities for Alcoa Corp and Neoleukin Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Alcoa and Neoleukin is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Alcoa Corp and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Alcoa Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alcoa Corp are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Alcoa Corp i.e., Alcoa Corp and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Alcoa Corp and Neoleukin Therapeutics
Allowing for the 90-day total investment horizon Alcoa Corp is expected to generate 0.71 times more return on investment than Neoleukin Therapeutics. However, Alcoa Corp is 1.41 times less risky than Neoleukin Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 3,315 in Alcoa Corp on August 27, 2024 and sell it today you would earn a total of 1,232 from holding Alcoa Corp or generate 37.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 9.38% |
| Values | Daily Returns |
Alcoa Corp vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Alcoa Corp |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Alcoa Corp and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alcoa Corp and Neoleukin Therapeutics
The main advantage of trading using opposite Alcoa Corp and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alcoa Corp position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.The idea behind Alcoa Corp and Neoleukin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |